Funding from the Bill & Melinda Gates Foundation will go toward understanding the benefits o novel cap analogs for therapeutic applications.Warsaw, December 8, 2022. ExPLoRNA Therapeutics, a Polish biotech company revolutionizing mRNA vaccines and therapeutics with unprecedented translational efficiency, received…
![](https://explorna.com/wp-content/uploads/2022/12/Cyrk9kpTURBXy8xMDk3MWJkNjMwMzExMmQzNTZlODE4MWQxMTc4MmNiZi5qcGeSlQMAzMTNCsDNBgyTBc0EsM0CWN4AAaEwAQ-850x450.jpg)
![](https://explorna.com/wp-content/uploads/2022/05/BIO-international-convention-2022-2-777x450.png)
Join us at the world’s largest event for the biotech industry #2022 BIO International Convention in San Diego (June 13-16, 2022). Let’s discuss the impact of innovative RNA modification technology on therapeutics and vaccines development. With passion, ExploRNA Therapeutics develops ground-breaking innovations of mRNA as…
![](https://explorna.com/wp-content/uploads/2022/03/webinafr-new-850x450.png)
We’re pleased to invite you to an exclusive webinar with our CTO and Co-founder Dr. Joanna Kowalska. Watch to learn about “Harnessing the Chemical Modifications of 5' Cap to Boost mRNA Expression in Vivo”. The webinar is organized by Precision…
![](https://explorna.com/wp-content/uploads/2022/03/RNA-Leaders-banner.png)
The Congress brings together the leading companies developing RNA-based therapeutics and is a global platform for advancing scientific and commercial collaborations, as well as sharing the recent advances and challenges of the field. Join Tomasz Piec, Board Member, and Piotr…